Free Republic

As you likely know by now, Jelly Roll has undergone a dramatic body transformation, losing nearly 300 pounds. But even though he insists he didn’t use GLP-1 drugs to help with his weight loss, some people still accuse him of not being truthful about it. Last month, Jelly Roll appeared on the cover of Men’s Health, where he spoke candidly about the speculation surrounding GLP-1 medications. He explained that he didn’t use GLP-1 drugs such as Ozempic or Mounjaro to lose nearly 300 pounds, saying he instead chose to focus on confronting the emotional and psychological roots of his food...

Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of the GLP-1 class of weight-loss drugs, including Ozempic, Wegovy and Mounjaro. In a new systematic review of existing research, led by professor Clare Collins of the Newcastle School of Health Sciences in New South Wales, Australia, it appears that very few global trials of the drugs have taken into consideration what and how much patients are eating while using them. This, experts have said, means many patients have been functionally malnourished — sometimes developing serious vitamin deficiencies...

(DCNF)—President Donald Trump announced Thursday that the price of Ozempic will fall from more than $1,000 to $199, a dramatic reduction for one of the most expensive and widely used prescription drugs in the country. Pharmacy “cash price” for a single Ozempic pen can exceed $1,300 at some U.S. outlets, according to pricing data. During the launch of Trump RX, Trump said manufacturers agreed to slash prices for popular GLP-1 weight-loss medications, insulin, asthma inhalers, and fertility drugs after sustained pressure from his administration.

The left always cares more about narrative than the truth. A split-second image can fuel outrage, define a story, and reshape public perception before facts even arrive. What happened in the Oval Office this week proves how easily that machine spins and how rare it is for decency to make the headline. Yet behind the noise lay a moment that said more about leadership than any carefully crafted address could. That moment came during a White House event on Thursday focused on expanding access to obesity treatments. In the middle of the ceremony, a guest suddenly collapsed in the Oval...

President Trump made an announcement today in the oval office highlighting two Rx companies, Eli Lilly and Company and Novo Nordisk, to dramatically reduce the prices Americans pay for some of the world’s most popular drugs. [Fact Sheet Here] Following the drug company announcement President Trump took questions from the media. The press Q&A is below and the full video including the announcement is below the fold. WATCH:

An attendee at President Donald Trump's drug pricing event on Thursday collapsed. A man identified as Novo Nordisk executive Gordon Findlay fainted just feet away from the president, who was seated at the Resolute Desk. The health scare led to the event being postponed, with White House aides quickly telling reporters that they needed to leave the Oval Office. Dr. Mehmet Oz, who serves as Trump's Administrator for the Centers for Medicare & Medicaid Services, jumped into action, guiding Findlay to the floor and then offering him medical attention. White House press secretary Karoline Leavitt didn't identify Findlay by name...

A Thursday Oval Office event, where President Donald Trump announced price reductions for weight-loss drugs, was interrupted by a health emergency. One of the attendees, Novo Nordisk executive Gordon Findlay, appeared to faint live on air during the event.

President Donald Trump this week cut deals with the drug-makers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health.

Novo Nordisk is the maker behind Ozempic and WegovyThe price of Novo Nordisk's blockbuster diabetes and weight loss-related drug Ozempic will be cut, according to President Donald Trump. Trump said this week during a White House event on fertility treatments and drug pricing the price reduction will come after swift negotiations with the drugmaker. "They'll be much lower," Trump told reporters. Novo Nordisk is the maker of Ozempic and Wegovy, which have the same active ingredient, semaglutide, but they are approved for different uses. Ozempic was approved by federal health officials in 2017 and marketed for medical use in the...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that these wildly popular medications may also be throwing off critical medical imaging scans, interfering with doctors’ ability to detect serious — even deadly — diseases. Experts say this could lead to delayed diagnoses and treatments for some patients, while others might undergo tests and procedures they didn’t need in the first place. Originally developed to treat Type 2 diabetes, GLP-1 meds have become a sensation due to their powerful weight-loss...

Sudden layoffs from jobs are tough to process and it gets worse when questions of employees remain unanswered. In one such case, an Indian employee detailed his sudden layoff from a US-based company in a Reddit post which has gone viral. According to the post, the employee was caught off guard by the termination, which took place on October 1, over a three-minute video call. “It was literally like any other day, woke up at 8:30, logged into work at 9 and saw a calendar invite for 11. It was a mandatory meeting with our COO for all India employees....

The president of Florida A&M University on Saturday said the historically Black college ("HBCU") was taking “immediate steps to ensure accountability” after its band announcer commented on the weight of Alabama State University’s Honey Beez dancers. During half-time of the game between the two schools, Florida A&M band announcer Joe Bullard called the dance team that performs with Alabama State’s Mighty Marching Hornets as “the new face of Ozempic,” HBCU Gameday reported. Dr. Quinton Ross, the president of Alabama State University, called the remark “distasteful” and “short-sighted.” “To have their artistry disrespected after such a performance is absolutely unacceptable,” Ross...

A new analysis of two large clinical trials reveals that a higher weekly dose of semaglutide (7.2 mg) can drive significantly greater weight loss and metabolic improvements in adults with obesity, including those with type 2 diabetes. Credit: Shutterstock =========================================================================== High-dose semaglutide drives greater weight loss. Safety remains favorable but needs further study. A weekly semaglutide dose of 7.2 mg has been shown to markedly enhance weight loss and improve health outcomes for adults with obesity, including those who also have type 2 diabetes (T2D). Evidence from two large, international phase 3 clinical trials, published in The Lancet Diabetes &...

Key Points Novo Nordisk said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price through multiple platforms. Patients can pay $499 in cash per month for three dose sizes of Ozempic through the drug’s official website, Novo Nordisk’s patient assistance program, the company’s recently launched direct-to-consumer online pharmacy and drug savings company GoodRx, among other platforms. It comes after Trump in July sent separate letters to Novo Nordisk and 16 other drugmakers, calling on them to take steps to lower medication prices in the U.S.

HealthWatch Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns healthwatch By Edited By May 13, 2025 / 1:03 PM EDT / CBS News Weight loss drugs have transformed how Americans lose weight, including former commissioner for the U.S. Food and Drug Administration Dr. David Kessler. But, Kessler warns there are unknowns about long-term use of the drugs and how to get people off them. "There is no end game," he said on "CBS Mornings Plus" Tuesday. "FDA allowed these medicines out without a long-term strategy." Kessler faced unexpected weight gain...

As a chef, self-educated nutritionist, and consultant to food-related businesses, I’ve witnessed firsthand the challenges facing the food retail industry. Restaurant owners and food service operators are grappling with declining sales and shifting consumer behaviors. Based on my experience and observations, three major factors are driving these concerns: the lingering effects of COVID-19 and inflation, the rise of weight loss drugs, and a perceived decline in overall food quality. However, with strategic adjustments—such as smaller portions, Ozempic-friendly options, lower-priced specials, and a vibrant happy hour—businesses can adapt and thrive in this evolving landscape. The Triple Threat to Food Retail COVID...

This gums up the works. Hollywood celebrities using popular weight loss drug Ozempic to shred those unwanted pounds are now facing an unexpected new side effect dubbed “Ozempic mouth,” according to a report. Users of the hottest prescription drug in Tinseltown, including Sharon Osbourne, Whoopie Goldberg, and Rebel Wilson, are showing signs of the distinctive side effect linked to rapid facial weight loss from a higher dose of the GLP-1 medication, a New York-based cosmetic dermatologist told the DailyMail.com “Many users of Ozempic who I know report noticeable volume loss in the face, which can result in the formation of...

As employee benefits evolve, a new contender has emerged, generating significant buzz in corporate America—coverage for weight-loss medications like Ozempic, Wegovy, and Zepbound. These GLP-1 agonists, originally developed for type 2 diabetes treatment but now widely sought after for their weight loss effects, are reshaping how employers think about health benefits and how employees evaluate job opportunities. Ozempic, a brand name for semaglutide, has become especially popular for its effectiveness in managing blood sugar levels and promoting weight loss. With list prices hovering around $1,350 for a four-week supply of Wegovy, these GLP-1 agonists remain financially out of reach for...

WW International, formerly known as WeightWatchers, has filed for Chapter 11 bankruptcy protection on Tuesday in a bid to cut its debt after Ozempic and other hugely popular obesity drugs upended its business model. Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in extended trading after announcing plans to file for bankruptcy as part of a reorganization plan with a group of its lenders. WeightWatchers began as weekly weight-loss support group meeting with 400 attendees, and quickly turned into a worldwide phenomena with millions of members across the...

The ‘Modern Family’ alum tells PEOPLE that he was initially "embarrassed" about his type 2 diabetes and kept his diagnosis a secret from friends and family Eric Stonestreet used to think his health was “fairly good.” He struggled to lose weight like many people, but felt fine overall. “I was just trying to maintain as healthy a lifestyle as I could without doing a tremendous amount about it,” he tells PEOPLE. But in 2009, just as he landed his beloved role as Cameron Tucker on Modern Family, Stonestreet was diagnosed with type 2 diabetes. “It was like this crazy happy...